Idarucizumab: What Should We Know?
Cortese F, Calculli G, Gesualdo M, Cecere A, Zito A, De Vito F, Carbonara R, Carbonara S, Cortese AM, Ciccone MM.
Cortese F, et al. Among authors: cortese am.
Curr Drug Targets. 2018;19(1):81-88. doi: 10.2174/1389450118666170925155943.
Curr Drug Targets. 2018.
PMID: 28950812
Review.